BenevolentAI
cash focused upon drug and platform development lab equipment computer property related leases charge from holdings gain from operational non transaction related equity awards removed from the no cash impact largely driven by outstanding tax credit receivable expected in and other payable decreases end june cash position of provides ample liquidity to meet multiple key value in points | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
69 of 74
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Conference
January 2024
cash focused upon drug and platform development flows | BenevolentAI
Results
March 2023
cash focused upon drug and platform development operating loss depreciation foreign exchange other employee related expense cash from changes in working capital cash expended from underlying operating activities opening cash cash equivalents and short term deposits closing cash cash equivalents and short term deposits property related leases gain from holdings gain from holdings charge from operational non transaction related equity awards removed from the no cash impact largely driven by increase in tax credit receivable as well as decrease in employer related tax provision year end cash position of at the top end of our stated guidance flows | BenevolentAI
Investor Presentation
October 2022
cash focused upon drug and platform development lab equipment computer property related leases charge from holdings gain from operational non transaction related equity awards removed from the no cash impact largely driven by outstanding tax credit receivable expected in and other payable decreases end june cash position of provides ample liquidity to meet multiple key value in points | BenevolentAI
Related slides by other companies
Nuvei
Results
August 2021
total volume total volume and revenue growth in compared to is operating model operating leverage leading to adjusted margin net stable and resilient diversification provides increased predictability and stability of results strong cash generation cash of at june and cash flow from operating activities of for the six months ended june | Nuvei
Telia Company
Results
November 2022
cash | Telia Company
SimCorp
Results
May 2022
cash flow development | SimCorp
ATAI
Investor Presentation
November 2022
mental health disorders have become one of global health burdens depression rates of us adults saw a increase since the onset of the covid pandemic as a response to the technical risks associated with drug development focuses on compound classes with prior evidence in humans and utilizes a decentralized drug development process active programs drug and discovery programs and enabling technologies focusing on potentially disease modifying therapies validation of operating model of compass pathways and validating license deal between perception we have a strong cash position of as of june and access to up to from term loan facility with giving cash runway into life sciences healing so that everyone everywhere can live more life | ATAI
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io